Valuation: Profarma Distribuidora de Produtos Farmacêuticos S.A.

Market Cap 82Cr 16Cr 14Cr 13Cr 12Cr 22Cr 1.51TCr 23Cr 152.71Cr 59Cr 737.11Cr 59Cr 58Cr 2.54TCr P/E 2024
6.95x
P/E 2025 9.42x
Enterprise Value 198.82Cr 38Cr 33Cr 31Cr 29Cr 54Cr 3.64TCr 55Cr 369.58Cr 143.18Cr 1.78TCr 143.41Cr 140.29Cr 6.15TCr EV / Sales 2024
0.18x
EV / Sales 2025 0.2x
Free-Float
32.86%
Yield 2024
8.86%
Yield 2025 -
07/05 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
16/03 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2025 CI
03/03 Brazil's Profarma to buy 4Bio from Raia Drogasil in 600 mln reais deal RE
05/11 Bmk, Bpl negotiate potential acquisition of Bpl shares in Brazil's Profarma RE
30/25/30 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
31/25/31 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
05/25/05 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
19/25/19 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024 CI
19/25/19 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 CI
31/24/31 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
07/24/07 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
08/24/08 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
07/24/07 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
1 day-1.32%
1 week+2.29%
Current month-1.32%
1 month-4.14%
3 months-21.98%
6 months-20.87%
Current year-26.51%
1 week 6.36
Extreme 6.36
6.94
1 month 6.16
Extreme 6.16
6.94
Current year 6.16
Extreme 6.16
9.7
1 year 6.16
Extreme 6.16
9.7
3 years 3.4
Extreme 3.4
9.7
5 years 2.92
Extreme 2.92
9.7
10 years 2.87
Extreme 2.87
11.79
Manager TitleAgeSince
Chief Executive Officer 57 21/04/2010
Director of Finance/CFO 68 01/01/1993
Director TitleAgeSince
Chairman 57 03/04/2008
Director/Board Member 91 21/04/2010
Director/Board Member 62 21/04/2010
Date Insider Type Main position Quantity % Market Cap.
08/25/08Others 1 0.0000%
09/24/09Sell 12,200 0.0099%
09/24/09Sell 12,400 0.0100%
Change 5-day change 1-year change 3-year change Capi.($)
-1.32%+2.29%-20.50%+72.94% 16Cr
+2.37%+2.58%+8.05%+84.01% 8.99TCr
+0.51%+2.54%+45.34%+152.66% 5.57TCr
-0.36%0.00%-8.08%+225.00% 2.17TCr
+1.73%+0.25%-10.81%-28.96% 776.06Cr
-0.27%+4.39%-28.28%-32.00% 763.26Cr
+3.27%+4.25%-10.61%-32.94% 633Cr
+3.12%+3.36%+20.32%+36.56% 629.46Cr
+1.83%+0.88%-1.77%+19.38% 522.19Cr
+2.75%+1.68%-5.27%-15.62% 346.41Cr
Average +1.36%+3.08%-1.16%+48.10% 2.04TCr
Weighted average by Cap. +1.49%+1.88%+13.72%+100.67%

Financials

2024 2025
Net sales 1.02TCr 195.07Cr 170.63Cr 156.68Cr 146.16Cr 276.74Cr 19TCr 281.88Cr 1.89TCr 731.25Cr 9.11TCr 732.41Cr 716.46Cr 31TCr 1.15TCr 219.99Cr 192.42Cr 176.69Cr 164.83Cr 312.09Cr 21TCr 317.88Cr 2.13TCr 824.65Cr 10TCr 825.96Cr 807.97Cr 35TCr
Net income 11Cr 2.2Cr 1.93Cr 1.77Cr 1.65Cr 3.12Cr 209.96Cr 3.18Cr 21Cr 8.25Cr 102.81Cr 8.26Cr 8.08Cr 354.57Cr 12Cr 2.28Cr 2Cr 1.83Cr 1.71Cr 3.24Cr 217.88Cr 3.3Cr 22Cr 8.56Cr 106.69Cr 8.58Cr 8.39Cr 367.93Cr
Net Debt 101.72Cr 20Cr 17Cr 16Cr 15Cr 28Cr 1.86TCr 28Cr 189.08Cr 73Cr 912.68Cr 73Cr 72Cr 3.15TCr 116.67Cr 22Cr 20Cr 18Cr 17Cr 32Cr 2.14TCr 32Cr 216.87Cr 84Cr 1.05TCr 84Cr 82Cr 3.61TCr
Logo Profarma Distribuidora de Produtos Farmacêuticos S.A.
Profarma Distribuidora de Produtos Farmaceuticos SA is a Brazil-based company primarily engaged in the wholesale trading of drugs. The Company's activities are divided into two segments: Pharmaceutical Distribution and Retail. The Pharmaceutical Distribution division is responsible for the wholesale of medicines and personal care and beauty products to pharmaceutical retailers. The Retail division focuses on the management of a pharmacies network under a number of brand names, such as Drogasmil and Tamoio. Its products range includes prescription drugs, over-the-counter (OTC) generics, personal hygiene articles and cosmetics, vaccines, dermatological products and hospital pharmaceuticals, among others. The Company's subsidiaries include Farmadacta Informatica Ltda, Promovendas Representacoes Ltda, Interagile Propaganda e Promocoes Ltda and Locafarma Solucoes de Transportes e Logistica Ltda, among others.
Employees
7,077
Date Price Change Volume
01/26/01 R$6.700 -1.47% 2,61,700
30/26/30 R$6.800 +1.34% 3,05,300
29/26/29 R$6.710 +1.82% 1,11,300
26/26/26 R$6.590 +0.46% 2,14,500
25/26/25 R$6.560 +2.18% 2,07,100
  1. Stock Market
  2. Stocks
  3. PFRM3 Stock